Brandon M. Weiss, Chelsea E. Sleep, Nicholas M. Beller, D. Erritzoe, W. K. Campbell
Studies have shown evidence for long-term effects of psychedelics on personality, but comprehensive models of psychedelic-mediated personality changes have yet to be explored.The present study aims to investigate (1) perceptions of personality change in the general population, (2) moderators of perceived personality change including setting and drug type, and (3) whether personality predisposes individuals to use psychedelics.Paid participants with experience using psychedelic (N = 218), non-users with interest in using psychedelics (N = 104), and non-users without interest in using psychedelic (N = 104) completed an online survey following recruitment from Amazon Mechanical Turk. Psychedelic users were asked to complete written open-ended accounts of perceived personality changes that they attribute to their most intense psychedelic experience. Thematic and factor analyses were undertaken to identify themes of perceived psychedelic change and their organizational structure.Thematic analyses resulted in 52 unique personality change themes, and exploratory factor analyses yielded eight thematic factors (Unitive Spiritual, Gratitude Absorption, Purpose Freedom, Compassion Understanding, Emotional Stability, Openness Perspective, Connection to Self, and Neuroticism Caution). Interest in psychedelic use among non-users was associated with higher openness and neuroticism. Psychedelic users tended to be more open and extraverted, and less neurotic than non-users, and interested non-users tended to be higher in openness than uninterested non-users.The present results inform a tentative model of how personality leads to psychedelic use, how psychedelic use leads to changes in personality, and how setting and drug moderate different types of changes in personality. Research and clinical implications are discussed, including (1) hypotheses for future prospective and experimental research, (2) the value of creating multi-faceted, holistic measures that reflect the diversity and organizational structure of possible psychedelic changes, and (3) the value of allowing such evidence to guide novel psychedelic-assisted therapeutics.
{"title":"Perceptions of psychedelic personality change, determinants of use, setting and drug moderation: Toward a holistic model","authors":"Brandon M. Weiss, Chelsea E. Sleep, Nicholas M. Beller, D. Erritzoe, W. K. Campbell","doi":"10.1556/2054.2023.00291","DOIUrl":"https://doi.org/10.1556/2054.2023.00291","url":null,"abstract":"Studies have shown evidence for long-term effects of psychedelics on personality, but comprehensive models of psychedelic-mediated personality changes have yet to be explored.The present study aims to investigate (1) perceptions of personality change in the general population, (2) moderators of perceived personality change including setting and drug type, and (3) whether personality predisposes individuals to use psychedelics.Paid participants with experience using psychedelic (N = 218), non-users with interest in using psychedelics (N = 104), and non-users without interest in using psychedelic (N = 104) completed an online survey following recruitment from Amazon Mechanical Turk. Psychedelic users were asked to complete written open-ended accounts of perceived personality changes that they attribute to their most intense psychedelic experience. Thematic and factor analyses were undertaken to identify themes of perceived psychedelic change and their organizational structure.Thematic analyses resulted in 52 unique personality change themes, and exploratory factor analyses yielded eight thematic factors (Unitive Spiritual, Gratitude Absorption, Purpose Freedom, Compassion Understanding, Emotional Stability, Openness Perspective, Connection to Self, and Neuroticism Caution). Interest in psychedelic use among non-users was associated with higher openness and neuroticism. Psychedelic users tended to be more open and extraverted, and less neurotic than non-users, and interested non-users tended to be higher in openness than uninterested non-users.The present results inform a tentative model of how personality leads to psychedelic use, how psychedelic use leads to changes in personality, and how setting and drug moderate different types of changes in personality. Research and clinical implications are discussed, including (1) hypotheses for future prospective and experimental research, (2) the value of creating multi-faceted, holistic measures that reflect the diversity and organizational structure of possible psychedelic changes, and (3) the value of allowing such evidence to guide novel psychedelic-assisted therapeutics.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138593285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This analysis of current and historical research and clinical reports observes that the relationship between psychedelics and schizophrenia is complex and there are reports of psychedelics benefiting this population. Specifically, lower doses of psychedelics (mostly LSD) appear to have a potential beneficial impact on the negative symptoms of schizophrenia.
{"title":"Psychedelics and schizophrenia: A mystery in history","authors":"Mark Haden, B. Woods, Sarah A. Paschall","doi":"10.1556/2054.2023.00277","DOIUrl":"https://doi.org/10.1556/2054.2023.00277","url":null,"abstract":"This analysis of current and historical research and clinical reports observes that the relationship between psychedelics and schizophrenia is complex and there are reports of psychedelics benefiting this population. Specifically, lower doses of psychedelics (mostly LSD) appear to have a potential beneficial impact on the negative symptoms of schizophrenia.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138607439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The Sonoran Desert Toad (Incilius alvarius) is the only vertebrate known to produce the powerful psychedelic, 5-MeO-DMT, which is easily-accessible form the animal's exterior glands. This paper seeks to present the biocultural (ecological and cultural) history, and conservation concerns of I. alvarius. Discovery of 5-MeO-DMT in I. alvarius was first reported in 1965 and 1967 (Erspamer et al.), and eventually led to the popular psychedelic use of this species after a pamphlet was published in 1984 (Most). Its mostly unmitigated use in for-profit spirituality, wellness, and adventurism has driven erroneous, coerced, and exploitive narratives of ancient Indigenous use – increasing: exploitation of I. alvarius, biocultural erosion, and malpractice of 5-MeO-DMT. Reconciliation of diverse needs is intellectually and financially challenging. It must be careful of approaches that are implicitly biased by a demand that extracts, appropriates, and trades in Indigenous and wellness motifs – but can be reached from the reconciliation and intersection of Indigenous and Western science and priorities. Few conservation-oriented studies and outreach elements concerning I. alvarius exist, and most have been supported by crowdfunding.
索诺兰沙漠蟾蜍（Incilius alvarius）是目前已知唯一能产生强效迷幻剂 5-MeO-DMT 的脊椎动物，这种迷幻剂很容易从动物的外部腺体获得。本文旨在介绍阿尔瓦里斯蛙的生物文化（生态和文化）历史和保护问题。1965年和1967年首次报道在阿尔瓦里斯蟾蜍体内发现了5-MeO-DMT（Erspamer等人），1984年出版的一本小册子（Most）最终导致了该物种迷幻药的流行。在以营利为目的的灵修、保健和冒险主义中，对这种物质的使用大多是不加节制的，这导致了对古老土著使用这种物质的错误、胁迫和剥削性叙述--对 I. alvarius 的开发、生物文化的侵蚀和 5-MeO-DMT 的不当使用日益增多。协调各种需求在智力和经济上都具有挑战性。必须小心那些暗含偏见的方法，这些偏见来自于对土著和健康主题的萃取、挪用和交易--但可以从土著和西方科学及优先事项的协调和交叉中达成。有关阿尔瓦里斯蛙的保护性研究和宣传内容很少，而且大多数都是通过众筹获得的。
{"title":"Toad in the road: Biocultural history and conservation challenges of the Sonoran Desert Toad","authors":"Robert A. Villa","doi":"10.1556/2054.2023.00269","DOIUrl":"https://doi.org/10.1556/2054.2023.00269","url":null,"abstract":"The Sonoran Desert Toad (Incilius alvarius) is the only vertebrate known to produce the powerful psychedelic, 5-MeO-DMT, which is easily-accessible form the animal's exterior glands. This paper seeks to present the biocultural (ecological and cultural) history, and conservation concerns of I. alvarius. Discovery of 5-MeO-DMT in I. alvarius was first reported in 1965 and 1967 (Erspamer et al.), and eventually led to the popular psychedelic use of this species after a pamphlet was published in 1984 (Most). Its mostly unmitigated use in for-profit spirituality, wellness, and adventurism has driven erroneous, coerced, and exploitive narratives of ancient Indigenous use – increasing: exploitation of I. alvarius, biocultural erosion, and malpractice of 5-MeO-DMT. Reconciliation of diverse needs is intellectually and financially challenging. It must be careful of approaches that are implicitly biased by a demand that extracts, appropriates, and trades in Indigenous and wellness motifs – but can be reached from the reconciliation and intersection of Indigenous and Western science and priorities. Few conservation-oriented studies and outreach elements concerning I. alvarius exist, and most have been supported by crowdfunding.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139198330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This scoping review employed a multifaceted conceptualization of well-being to examine how psilocybin use affects well-being and related sub-concepts in healthy individuals. It investigated which factors influence the relationship between psilocybin use and well-being, what research protocols have been employed, and what underlying mechanisms have been proposed in existing studies.A comprehensive literature search in line with the PRISMA guidelines was conducted. Scopus, PubMed, PsycINFO, Web of Science, and Google Scholar were searched for peer-reviewed articles about psilocybin and well-being in healthy populations.Studies were heterogeneous in regard to study objectives, study design, study procedure, sample size and psilocybin dosage. In all studies, psilocybin use led to positive well-being-related outcomes for the majority of participants. Facets of well-being positively affected by psilocybin use in this review were self-acceptance, positive relationships, and meaning/purpose in life.This scoping review provided preliminary evidence for the beneficial effects of psilocybin on well-being and related sub-concepts such as self-acceptance, positive relationships, and meaning/purpose in life in healthy individuals. Ego-dissolution, unity, connectedness, and mystical-type experiences are interrelated concepts that seem to be crucial for explaining such positive well-being-related effects of psilocybin. Under conducive conditions, the use of psilocybin may contribute to healthy functioning, through broad and sustained improvements in a variety of well-being concepts. Due to the heterogeneous nature of the studies, more definite conclusions require further research with a rigorous and homogeneous design.
本次范围界定综述采用了幸福感的多层面概念，以研究使用迷幻药如何影响健康人的幸福感及相关子概念。它调查了哪些因素会影响使用迷幻药与幸福感之间的关系，采用了哪些研究方案，以及现有研究提出了哪些潜在机制。在 Scopus、PubMed、PsycINFO、Web of Science 和 Google Scholar 中搜索了有关健康人群中使用迷幻药和幸福感的同行评审文章。在所有研究中，大多数参与者服用迷幻药后都获得了与幸福感相关的积极结果。在本综述中，使用迷幻药对幸福感产生积极影响的方面包括自我接纳、积极的人际关系和生活意义/目的。本范围综述提供了初步证据，证明迷幻药对健康人的幸福感及相关子概念（如自我接纳、积极的人际关系和生活意义/目的）产生有益影响。自我解体、统一性、联系性和神秘型体验这些相互关联的概念似乎是解释迷幻药对幸福感产生积极影响的关键。在有利的条件下，使用迷幻药可能会通过广泛而持续地改善各种幸福概念来促进健康功能。由于这些研究的性质各不相同，要得出更明确的结论，还需要进一步开展严谨和同质化设计的研究。
{"title":"The potential of psilocybin use to enhance well-being in healthy individuals – A scoping review","authors":"Lennart Wiepking, Ed de Bruin, Alexandra Ghiţă","doi":"10.1556/2054.2023.00244","DOIUrl":"https://doi.org/10.1556/2054.2023.00244","url":null,"abstract":"This scoping review employed a multifaceted conceptualization of well-being to examine how psilocybin use affects well-being and related sub-concepts in healthy individuals. It investigated which factors influence the relationship between psilocybin use and well-being, what research protocols have been employed, and what underlying mechanisms have been proposed in existing studies.A comprehensive literature search in line with the PRISMA guidelines was conducted. Scopus, PubMed, PsycINFO, Web of Science, and Google Scholar were searched for peer-reviewed articles about psilocybin and well-being in healthy populations.Studies were heterogeneous in regard to study objectives, study design, study procedure, sample size and psilocybin dosage. In all studies, psilocybin use led to positive well-being-related outcomes for the majority of participants. Facets of well-being positively affected by psilocybin use in this review were self-acceptance, positive relationships, and meaning/purpose in life.This scoping review provided preliminary evidence for the beneficial effects of psilocybin on well-being and related sub-concepts such as self-acceptance, positive relationships, and meaning/purpose in life in healthy individuals. Ego-dissolution, unity, connectedness, and mystical-type experiences are interrelated concepts that seem to be crucial for explaining such positive well-being-related effects of psilocybin. Under conducive conditions, the use of psilocybin may contribute to healthy functioning, through broad and sustained improvements in a variety of well-being concepts. Due to the heterogeneous nature of the studies, more definite conclusions require further research with a rigorous and homogeneous design.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139210289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Psychedelic-assisted therapy (P-AT) has been shown to reduce post-traumatic stress disorder (PTSD), depression, and anxiety symptoms, and is likely to be approved in the United States (US) in the coming years. However, concerns about participant safety in these early trials have surfaced, including allegations of sexual misconduct. This paper aims to illuminate how potential risks have been communicated to P-AT participants via informed consent documents and to suggest how existing policy might be modified given the unique risks involved in P-AT trials.Publicly available informed consent forms (ICFs) were gathered by searching clinicaltrials.gov. Queries were applied to filter trials involving the use of a classical psychedelic (psilocybin, LSD) or psychedelic-adjacent substance (MDMA, ketamine) in tandem with psychotherapeutic intervention and those with a status of “completed,” “recruiting,” or “active.”Nineteen ICFs met inclusion criteria and were reviewed to determine what risks, benefits, and safety protocols were communicated to participants in their respective trials. The primary finding from this review of ICFs from P-AT trials revealed that studies were in compliance with federal regulation. However, there were missing elements related to the vulnerability experienced while under the effects of psychedelics that warrant inclusion in future ICFs in P-AT trials.Although the ICFs for P-AT trials examined in this study covered several important areas related to risk, benefits, safety, and accountability as required by federal regulations in the US, future research should consider ways to expand this content in order to assure that consent is truly informed prior to enrolling subjects.
{"title":"Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials","authors":"Tahlia R. Harrison","doi":"10.1556/2054.2023.00267","DOIUrl":"https://doi.org/10.1556/2054.2023.00267","url":null,"abstract":"Psychedelic-assisted therapy (P-AT) has been shown to reduce post-traumatic stress disorder (PTSD), depression, and anxiety symptoms, and is likely to be approved in the United States (US) in the coming years. However, concerns about participant safety in these early trials have surfaced, including allegations of sexual misconduct. This paper aims to illuminate how potential risks have been communicated to P-AT participants via informed consent documents and to suggest how existing policy might be modified given the unique risks involved in P-AT trials.Publicly available informed consent forms (ICFs) were gathered by searching clinicaltrials.gov. Queries were applied to filter trials involving the use of a classical psychedelic (psilocybin, LSD) or psychedelic-adjacent substance (MDMA, ketamine) in tandem with psychotherapeutic intervention and those with a status of “completed,” “recruiting,” or “active.”Nineteen ICFs met inclusion criteria and were reviewed to determine what risks, benefits, and safety protocols were communicated to participants in their respective trials. The primary finding from this review of ICFs from P-AT trials revealed that studies were in compliance with federal regulation. However, there were missing elements related to the vulnerability experienced while under the effects of psychedelics that warrant inclusion in future ICFs in P-AT trials.Although the ICFs for P-AT trials examined in this study covered several important areas related to risk, benefits, safety, and accountability as required by federal regulations in the US, future research should consider ways to expand this content in order to assure that consent is truly informed prior to enrolling subjects.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139254954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Psychedelic Integration: Psychotherapy for non-ordinary states of consciousness","authors":"Danelle Jones","doi":"10.1556/2054.2023.00306","DOIUrl":"https://doi.org/10.1556/2054.2023.00306","url":null,"abstract":"","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139268717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Psychedelic Justice: Toward a diverse and equitable psychedelic culture","authors":"Danelle Jones","doi":"10.1556/2054.2023.00315","DOIUrl":"https://doi.org/10.1556/2054.2023.00315","url":null,"abstract":"","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139270096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abstract Background and aims Microdosing psychedelics refers to the practice of repeatedly ingesting doses that do not reach the threshold for perceptual alterations. This practice has gained attention from mass media, businesses, and the general public, as evidenced by the proliferation of online communities dedicated to it. In this contribution, we examine the content generated within the online community r/microdosing from its creation on October 16, 2013, until the day of data collection on October 31, 2020. Our aim is to examine the narratives reflected by users' contributions, specifically the compatibility or incompatibility of spiritual and scientific narratives. Methods In this contribution, we used text analysis techniques and examined the content generated within the online community r/microdosing from its creation on October 16, 2013, until the day of data collection on October 31, 2020. Results We clearly identified a topic that reflects a spirituality narrative as well as a topic that we coined as “neuro-cognition” and that reflects a scientific narrative. These topics were typically not present within the contributions of the same users, suggesting that the scientific and spiritual narratives are segregated within the r/subreddit community. Conclusion Our approach emphasizes the potential of text analytic techniques for uncovering the cultural repertoire surrounding a particular practice, in our case, the practice of microdosing psychedelics.
{"title":"Microdosing psychedelics: The segregation of spiritual and scientific narratives within the r/microdosing online community","authors":"Ioana Pop, Erwin Gielens, Hannah Kottmann","doi":"10.1556/2054.2023.00260","DOIUrl":"https://doi.org/10.1556/2054.2023.00260","url":null,"abstract":"Abstract Background and aims Microdosing psychedelics refers to the practice of repeatedly ingesting doses that do not reach the threshold for perceptual alterations. This practice has gained attention from mass media, businesses, and the general public, as evidenced by the proliferation of online communities dedicated to it. In this contribution, we examine the content generated within the online community r/microdosing from its creation on October 16, 2013, until the day of data collection on October 31, 2020. Our aim is to examine the narratives reflected by users' contributions, specifically the compatibility or incompatibility of spiritual and scientific narratives. Methods In this contribution, we used text analysis techniques and examined the content generated within the online community r/microdosing from its creation on October 16, 2013, until the day of data collection on October 31, 2020. Results We clearly identified a topic that reflects a spirituality narrative as well as a topic that we coined as “neuro-cognition” and that reflects a scientific narrative. These topics were typically not present within the contributions of the same users, suggesting that the scientific and spiritual narratives are segregated within the r/subreddit community. Conclusion Our approach emphasizes the potential of text analytic techniques for uncovering the cultural repertoire surrounding a particular practice, in our case, the practice of microdosing psychedelics.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135343000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sam Elias, Stephanie Spivak, Alexa Alverez, Alejandro Gili Olivares, Maria Ferrol, Julian Paul Keenan
Abstract Introduction It is not known how self-perception and self-recognition are influenced when one is highly self-focused under the influence of psilocybin. Here we examine self-reports of mirror self-recognition and self-perception during a psilocybin experience. Methods Reddit posts were examined in a systematic manner. Posts that were written by individuals that ingested psilocybin and subsequently looked in a mirror were examined. After both automatic and manual filtering, a total of 89 posts with 775 post excerpts were analyzed. Results It was found that it was rare to see one's own face as a different entity (e.g., an animal or other person) however people were equally likely to see themselves as they really are or distorted. People were significantly more positive than negative when perceiving their own face. Discussion We found wide variation in the perception of the own-face while under the influence of psilocybin. While generally positive, the self-face appears to be an experience that varies dramatically from person to person under the influence of psilocybin.
{"title":"Self-perception and self-recognition while looking in the mirror on psilocybin","authors":"Sam Elias, Stephanie Spivak, Alexa Alverez, Alejandro Gili Olivares, Maria Ferrol, Julian Paul Keenan","doi":"10.1556/2054.2023.00251","DOIUrl":"https://doi.org/10.1556/2054.2023.00251","url":null,"abstract":"Abstract Introduction It is not known how self-perception and self-recognition are influenced when one is highly self-focused under the influence of psilocybin. Here we examine self-reports of mirror self-recognition and self-perception during a psilocybin experience. Methods Reddit posts were examined in a systematic manner. Posts that were written by individuals that ingested psilocybin and subsequently looked in a mirror were examined. After both automatic and manual filtering, a total of 89 posts with 775 post excerpts were analyzed. Results It was found that it was rare to see one's own face as a different entity (e.g., an animal or other person) however people were equally likely to see themselves as they really are or distorted. People were significantly more positive than negative when perceiving their own face. Discussion We found wide variation in the perception of the own-face while under the influence of psilocybin. While generally positive, the self-face appears to be an experience that varies dramatically from person to person under the influence of psilocybin.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135343145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abstract Questions are currently being posed concerning the implications of the clinical uptake of psychedelics. While enthusiasm surrounds the potential therapeutic benefits of psychedelics and critique surrounds their appropriation to commercial ends, limited attention has been given to the role of psychedelics in generating social transformation. Herbert Marcuse contended radical change requires ‘new imaginaries of liberation’. We consider whether clinical uptake of psychedelics may produce the perceptual shifts necessary to generate social transformation surrounding contemporary alienating conditions. Economic structures contributing to these alienating conditions are highly resistant to change and may neuter psychedelics' revolutionary potential. We illustrate how psychedelics may be instrumentalised: regulating individuals into unjust systems; redirecting psychedelic usage away from therapeutic ends towards productivity; distracting or diverting attention from systemic forms of control; usurping non-ordinary states into the domain of self-care; and fetishistically commodifying psychedelic experience as a consumable. There are, however, reasons to believe that psychedelics, in raising consciousnesses, may prove resistant to co-option. In particular, psychedelics induce perceptual experiences that: challenge the paradigmatic assumptions of industrial society by provoking alternative epistemologies and metaphysics; generate expanded or ecological constructions of selfhood, thereby offering resignifications of meanings, desires, and life potentials; and offer the enriched phenomenological insight into self, other, and world called for in combating ubiquitous social alienation. In this way, psychedelics may induce the revolution in perception necessary to imagine liberatory potentials and spark the desire for collective emancipation.
{"title":"Evaluating the role of psychedelic psychotherapy in addressing societal alienation: Imaginaries of liberation","authors":"Julien Tempone-Wiltshire, Floren Matthews","doi":"10.1556/2054.2023.00275","DOIUrl":"https://doi.org/10.1556/2054.2023.00275","url":null,"abstract":"Abstract Questions are currently being posed concerning the implications of the clinical uptake of psychedelics. While enthusiasm surrounds the potential therapeutic benefits of psychedelics and critique surrounds their appropriation to commercial ends, limited attention has been given to the role of psychedelics in generating social transformation. Herbert Marcuse contended radical change requires ‘new imaginaries of liberation’. We consider whether clinical uptake of psychedelics may produce the perceptual shifts necessary to generate social transformation surrounding contemporary alienating conditions. Economic structures contributing to these alienating conditions are highly resistant to change and may neuter psychedelics' revolutionary potential. We illustrate how psychedelics may be instrumentalised: regulating individuals into unjust systems; redirecting psychedelic usage away from therapeutic ends towards productivity; distracting or diverting attention from systemic forms of control; usurping non-ordinary states into the domain of self-care; and fetishistically commodifying psychedelic experience as a consumable. There are, however, reasons to believe that psychedelics, in raising consciousnesses, may prove resistant to co-option. In particular, psychedelics induce perceptual experiences that: challenge the paradigmatic assumptions of industrial society by provoking alternative epistemologies and metaphysics; generate expanded or ecological constructions of selfhood, thereby offering resignifications of meanings, desires, and life potentials; and offer the enriched phenomenological insight into self, other, and world called for in combating ubiquitous social alienation. In this way, psychedelics may induce the revolution in perception necessary to imagine liberatory potentials and spark the desire for collective emancipation.","PeriodicalId":34732,"journal":{"name":"Journal of Psychedelic Studies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135814907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：